Precipio, Inc. Logo

Precipio, Inc.

Provides blood cancer diagnostic services & products to improve accuracy for physicians & labs.

PRPO | US

Overview

Corporate Details

ISIN(s):
US74112Q1022 (+1 more)
LEI:
Country:
United States of America
Address:
12325 EMMET ST, 68164 OMAHA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Precipio, Inc. is a healthcare biotechnology company focused on eradicating cancer misdiagnosis through advanced hematopathology diagnostics. The company operates a dual business model, offering both clinical diagnostic services and proprietary diagnostic products. Its Clinical Services division provides high-accuracy blood cancer testing directly to physicians. The Products Division develops and commercializes technologies for other laboratories, including the HemeScreen® and Bloodhound™ molecular diagnostic kits for detecting mutations in blood cancers like AML and CML, and the IV-Cell™ culture media. By translating insights from its own clinical laboratory into commercial products, Precipio aims to provide solutions that enhance diagnostic accuracy, improve laboratory efficiency, and ensure patients receive correct diagnoses from the start.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Precipio, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Precipio, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Precipio, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
China SXT Pharmaceuticals, Inc. Logo
Researches, produces, and sells advanced Traditional Chinese Medicine (TCM) herbal products.
United States of America SXTC
ChoA Pharmaceutical Co., LTD. Logo
Global manufacturer of OTC medicines and health supplements distributed through pharmacies.
South Korea 034940
CHUGAI PHARMACEUTICAL CO., LTD. Logo
An R&D pharma leader in Japan creating innovative drugs via antibody engineering technology.
Japan 4519
Cinclus Pharma Holding AB Logo
Clinical-stage pharma developing a next-gen P-CAB drug for severe GERD patients.
Sweden CINPHA
Cingulate Inc. Logo
Developing once-daily, precision timed-release drugs for ADHD and anxiety.
United States of America CING
Circio Holding ASA Logo
Developing circular RNA vector tech and immunotherapies for gene and cell therapies.
Norway CRNA
CITIUS ONCOLOGY, INC. Logo
Commercializing LYMPHIR™, an FDA-approved targeted therapy for cutaneous T-cell lymphoma.
United States of America CTOR
Citius Pharmaceuticals, Inc. Logo
Late-stage biopharma developing critical care products for oncology, infections, and stem cells.
United States of America CTXR
CJ Bioscience Logo
Develops microbiome therapeutics for oncology & IBD using an AI drug discovery platform.
South Korea 311690
CKD Bio Corp. Logo
Develops and manufactures probiotics & APIs using fermentation, also offering cGMP CMO services.
South Korea 063160

Talk to a Data Expert

Have a question? We'll get back to you promptly.